Renaissance Technologies - CALITHERA BIOSCIENCES INC ownership

CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 57 filers reported holding CALITHERA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CALITHERA BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$749,000
-17.1%
1,853,500
+36.5%
0.00%0.0%
Q4 2021$903,000
+9.5%
1,357,400
+258.5%
0.00%0.0%
Q3 2021$825,000
-45.5%
378,600
-47.8%
0.00%
-50.0%
Q2 2021$1,515,000
+11.6%
725,082
+29.3%
0.00%0.0%
Q1 2021$1,357,000
-13.6%
560,855
+75.3%
0.00%0.0%
Q4 2020$1,571,000
-60.7%
319,900
-72.4%
0.00%
-50.0%
Q3 2020$3,996,000
-28.3%
1,158,311
+9.8%
0.00%
-20.0%
Q2 2020$5,571,000
+13.0%
1,055,127
-5.0%
0.01%0.0%
Q1 2020$4,929,000
-28.2%
1,110,089
-7.7%
0.01%0.0%
Q4 2019$6,869,000
+106.0%
1,203,011
+11.5%
0.01%
+66.7%
Q3 2019$3,334,000
+13.9%
1,078,803
+43.8%
0.00%0.0%
Q2 2019$2,926,000
-11.4%
750,198
+53.0%
0.00%0.0%
Q1 2019$3,304,000
+217.7%
490,198
+89.0%
0.00%
+200.0%
Q4 2018$1,040,000
+738.7%
259,298
+999.3%
0.00%
Q3 2018$124,000
-95.1%
23,588
-94.5%
0.00%
-100.0%
Q2 2018$2,508,000
+47.5%
431,500
+59.9%
0.00%
-50.0%
Q1 2018$1,700,000
-53.0%
269,900
-37.7%
0.00%
-50.0%
Q4 2017$3,615,000
+43.9%
432,956
+171.4%
0.00%
+33.3%
Q3 2017$2,512,000
+737.3%
159,500
+72.5%
0.00%
+200.0%
Q3 2016$300,00092,4450.00%
Other shareholders
CALITHERA BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,426,702$5,290,0003.82%
BVF INC/IL 7,452,331$16,246,0000.63%
TSP Capital Management Group, LLC 661,600$1,442,0000.49%
SILVERARC CAPITAL MANAGEMENT, LLC 186,245$406,0000.23%
GSA CAPITAL PARTNERS LLP 525,667$1,146,0000.12%
Parkman Healthcare Partners LLC 100,628$219,0000.06%
FEDERATED HERMES, INC. 6,668,978$14,539,0000.03%
FRANKLIN STREET ADVISORS INC /NC 133,700$291,0000.02%
Ergoteles LLC 274,805$599,0000.02%
Seelaus Asset Management LLC 16,150$35,0000.02%
View complete list of CALITHERA BIOSCIENCES INC shareholders